These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 28674049)

  • 41. Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan.
    Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
    J Med Microbiol; 2018 Jan; 67(1):74-82. PubMed ID: 29227218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thiostrepton: A Novel Therapeutic Drug Candidate for
    Kim TH; Hanh BTB; Kim G; Lee DG; Park JW; Lee SE; Kim JS; Kim BS; Ryoo S; Jo EK; Jang J
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835481
    [No Abstract]   [Full Text] [Related]  

  • 43. Oxazolidinone antimicrobials: a patent review (2012-2015).
    Phillips OA; Sharaf LH
    Expert Opin Ther Pat; 2016 May; 26(5):591-605. PubMed ID: 26998627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic Evolution of
    Li B; Guo Q; Mao Y; Zou Y; Zhang Y; Zhang Z; Chu H
    Can Respir J; 2020; 2020():7623828. PubMed ID: 32300380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment.
    Meir M; Grosfeld T; Barkan D
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
    Ruth MM; Koeken VACM; Pennings LJ; Svensson EM; Wertheim HFL; Hoefsloot W; van Ingen J
    J Antimicrob Chemother; 2020 Mar; 75(3):609-617. PubMed ID: 31886864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful management of Mycobacterium abscessus pneumonia in a 53-day-old immunocompetent infant.
    Sun JM; Li J; Xu XH
    Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116296. PubMed ID: 38640607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.
    Choi H; Jhun BW; Kim SY; Kim DH; Lee H; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):293-295. PubMed ID: 29329759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in
    Ruth MM; van Rossum M; Koeken VACM; Pennings LJ; Svensson EM; Ruesen C; Bowles EC; Wertheim HFL; Hoefsloot W; van Ingen J
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262763
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vancomycin and Clarithromycin Show Synergy against
    Mukherjee D; Wu ML; Teo JWP; Dick T
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.
    Kumar P; Chauhan V; Silva JRA; Lameira J; d'Andrea FB; Li SG; Ginell SL; Freundlich JS; Alves CN; Bailey S; Cohen KA; Lamichhane G
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic Efficacy of β-Lactam Combinations against
    Story-Roller E; Maggioncalda EC; Lamichhane G
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109979
    [No Abstract]   [Full Text] [Related]  

  • 53. Indole-2-Carboxamides Are Active against
    Pandya AN; Prathipati PK; Hegde P; Li W; Graham KF; Mandal S; Drescher KM; Destache CJ; Ordway D; Jackson M; North EJ
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics.
    Nie W; Duan H; Huang H; Lu Y; Bi D; Chu N
    Int J Infect Dis; 2014 Aug; 25():170-4. PubMed ID: 24932856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ex vivo infection of murine precision-cut lung tissue slices with Mycobacterium abscessus: a model to study antimycobacterial agents.
    Molina-Torres CA; Flores-Castillo ON; Carranza-Torres IE; Guzmán-Delgado NE; Viveros-Valdez E; Vera-Cabrera L; Ocampo-Candiani J; Verde-Star J; Castro-Garza J; Carranza-Rosales P
    Ann Clin Microbiol Antimicrob; 2020 Nov; 19(1):52. PubMed ID: 33222688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against
    Lee DG; Hwang YH; Park EJ; Kim JH; Ryoo SW
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681686
    [No Abstract]   [Full Text] [Related]  

  • 57.
    Kaushik A; Ammerman NC; Martins O; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents.
    Yoshida S; Tsuyuguchi K; Suzuki K; Tomita M; Okada M; Hayashi S; Iwamoto T; Saito H
    Int J Antimicrob Agents; 2013 Sep; 42(3):226-31. PubMed ID: 23850022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against
    Moore JE; Koulianos G; Hardy M; Misawa N; Millar BC
    Int J Mycobacteriol; 2018; 7(3):265-267. PubMed ID: 30198508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Analysis of Linezolid-Resistant Clinical Isolates of
    Ye M; Xu L; Zou Y; Li B; Guo Q; Zhang Y; Zhan M; Xu B; Yu F; Zhang Z; Chu H
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.